March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
RAAB+DR - Rapid Assessment of Blindness Including Diabetes: Results of a New Population-based Survey Method in Chiapas (Mexico), Cape Town (South Africa), and Taif (Saudi Arabia)
Author Affiliations & Notes
  • David B. Yorston
    Tennent Institute of Ophthalmology, Gartnavel Hospital, Glasgow, United Kingdom
    London School of Hygiene & Tropical Medicine, International Centre for Eye Health, London, United Kingdom
  • Sarah Polack
    London School of Hygiene & Tropical Medicine, International Centre for Eye Health, London, United Kingdom
  • Hannah Kuper
    London School of Hygiene & Tropical Medicine, International Centre for Eye Health, London, United Kingdom
  • Nicole Cockburn
    University of Cape Town, Cape Town, South Africa
  • Pedro Gomez
    Instituto de la Vision Universidad de Montemorelos, Montemorelos, N.L., Mexico
  • Mansur Rabiu
    Prevention of Blindness Union, Riyadh, Saudi Arabia
  • Footnotes
    Commercial Relationships  David B. Yorston, None; Sarah Polack, None; Hannah Kuper, None; Nicole Cockburn, None; Pedro Gomez, None; Mansur Rabiu, None
  • Footnotes
    Support  Fight for Sight
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 6345. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      David B. Yorston, Sarah Polack, Hannah Kuper, Nicole Cockburn, Pedro Gomez, Mansur Rabiu; RAAB+DR - Rapid Assessment of Blindness Including Diabetes: Results of a New Population-based Survey Method in Chiapas (Mexico), Cape Town (South Africa), and Taif (Saudi Arabia). Invest. Ophthalmol. Vis. Sci. 2012;53(14):6345.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose:
 

To assess the feasibility of using a modified Rapid Assessment of Avoidable Blindness framework to estimate diabetic retinopathy (DR) prevalence, and its contribution to visual impairment in three low and middle income countries.

 
Methods:
 

Clusters of 50 (40 in South Africa) people aged 50 years or older were selected by probability proportionate to size sampling. Households within clusters were selected through compact segment sampling. Participants underwent visual acuity (VA) screening and diagnosis of cause of visual impairment by an ophthalmologist. Participants were classed as ‘Diabetic’ if they had a previous diagnosis of diabetes, were receiving treatment for blood glucose control or had a random blood glucose level >200mg/dl. Diabetic participants were assessed for DR using: dilated clinical examination (direct and indirect ophthalmoscope) and one dilated digital fundus photograph per eye (graded by a retinal specialist - "reference standard") following the Scottish DR grading protocol. The main outcome measures were: prevalence of blindness (VA<20/400 in the best eye with available correction) and prevalence of DR.

 
Results:
 

DR prevalence is shown in the table. The prevalence of blindness was 2.3%(1.7-2.9) in Chiapas, 1.4%(0.9-1.8) in Cape Town, and 2.6%(2.0-3.2) in Taif. Cataract caused 63% of blindness in Chiapas 41% in Taif and 27% in Cape Town. Posterior segment diseases were responsible for 24% of blindness in Chiapas, 44% in Taif and 65% in Cape Town. DR caused 8% of blindness in Chiapas, 8% in Cape Town, and 10% in Taif.

 
Conclusions:
 

The prevalence of diabetes and DR was high in all three centers. The surveys show that there is an unmet need for both laser treatment and for programs to detect and treat DR. It was feasible to include assessment of DR within the survey and the results will assist program planning. Including the DR component added to the cost and complexity of the survey, and so would only be warranted if a high prevalence of diabetes is expected, and if resources and time permit.  

 
Keywords: diabetic retinopathy • clinical (human) or epidemiologic studies: prevalence/incidence 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×